Please login to the form below

Not currently logged in
Email:
Password:

Medivir names new CEO

Niklas Prager has experience at Merck & Co and Pfizer
medivir niklas prager

Medivir has named board member Niklas Prager as the company's new CEO replacing Maris Hartmanis.

Prager, who has served on the board of the Swedish biopharma since May 2014, will assume his new position on September 1, 2014.

Birgitta Stymne Göransson, chairman of the board of directors of Medivir, said: “Niklas has a background in both biotech and big pharma, and his large network of contacts in the Swedish and international pharmaceutical industries make him an ideal choice for us.

“Niklas will in particular be able to contribute and strengthen Medivir in the important areas of strategic business development and commercialisation.”

Prager's previous companies include Merck & Co, where he served in both the US and Sweden. His other roles include CEO of Pfizer's business in Sweden.

Commenting on his new position, he highlighted Medivir's work with Johnson & Johnson to develop the hepatitis C treatment Olysio (simeprevir).

“Medivir is an attractive company in an exciting phase of its development following the successful market introduction of simeprevir,” he said.

“An update of Medivir's strategic plan is the number one priority, and work on this is already well under way.”

13th August 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics